(Date:11/25/2009)...swire/ -- Biotech firm Replikins Ltd., which has a... pandemic through the prediction, outbreak, and pr...its latest biochemical analysis of the virus. The ...ine Flu") virus has dropped from its peak of 3.7 (...he spring of 2009 to resting non-epidemic levels t...
(Date:11/25/2009)...wire/ - Cytochroma today announced the appointment.... Moldt will replace Mr. Ulrik Spork as the Novo A...er of Board members remains unchanged at six membe...ldt to the board and look forward to benefiting fr...nues to make progress in becoming a leading CKD-fo...
(Date:11/25/2009)...ire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq:...m.D., president and chief executive officer, will ...re Conference. , ,Presentation details are as fol...rence,Date: Tuesday, December 1, 2009,Time: ... Palace Hotel, New York, NY,Webcast: <a href=,h...
(Date:11/24/2009)...also Visit Detroit , (Voc...ench Ambassador for International Investment, and ... , , ,What: Ambassador Appia is available to meet...ives adopted by France to further develop the fina...n and development., , ,When: Available for Intervi...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2(Date:11/30/2009)..., , COVINA, Calif., Nov. 30 /PRNewswire... and commercialization agreement with Academia Sin...n proprietary methods and Intellectual Property (I... stem cells. This method and IP was pioneered by ...ers of Academia Sinica. Professor Lin is currentl...
(Date:11/30/2009)..., , KING OF PRUSSIA, Pa., Nov. 30 /PRNew...unced the completion of a Phase I study of CPSI-23... the production of TNF-alpha and other pro-inflamm...bility dose escalation study in healthy volunteers...inical testing. ,, All 30 enrolled subjects c...
(Date:11/30/2009)..., , WALTHAM, Mass., Nov. 30 /PRNews...RG), the global authority on medical technology ma...facial injectable market declined by almost 5% ove...ent as a result of the economic crisis. The market...4, will return to the strong pre-recession growth ...
Breaking Medicine Technology:StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Centene Corporation to Present at Bank of America Merrill Lynch Credit Conference 61862 1Why Holidays Dont Have To Be Happy 61860 1Why Holidays Dont Have To Be Happy 61860 2SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 1SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 2SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 3SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 4SIRIUS XM to Broadcast Doctor Radio Reports 3A What Every Woman Needs To Know About Mammograms 61858 5